English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsOpinionPain points ease for pharma companies, but no earnings upgrades yet

    Pain points ease for pharma companies, but no earnings upgrades yet

    Raw material cost inflation eased and US revenues grew at most large drug firms in the December 2022 quarter

    R. Sree Ram
    February 23, 2023 / 11:57 IST
    India revenues continued to grow for most pharma companies. With patient visits to hospitals normalising, pharma companies expanded the field-force. This helped drive sales
    • PRO Panorama

      Moneycontrol Pro Panorama | HCL Tech dispels gloom in IT sector

      Oct 14, 2025 / 02:49 PM IST

      For Moneycontrol's Pro Panorama October 14 edition: LIC struggles to find growth amid low returns, silver ETFs may be the road ahe...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts